Section 5-405 - Schedule IV.
§ 5-405. Schedule IV.
(a) In general.- Schedule IV consists of each controlled dangerous substance:
(1) listed in this section;
(2) added to Schedule IV by the Department under § 5-202(b) of this title; or
(3) designated as a Schedule IV controlled dangerous substance by the federal government unless the Department objects under § 5-202(f) of this title.
(b) Core substances.- Substances listed in Schedule IV include a material, compound, mixture, or preparation that contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system:
(1) barbital;
(2) bromazepam;
(3) camazepam;
(4) chloral betaine;
(5) chloral hydrate;
(6) ethchlorvynol;
(7) chlordiazepoxide;
(8) clobazam;
(9) clonazepam;
(10) clorazepate;
(11) clotiazepam;
(12) cloxazolam;
(13) delorazepam;
(14) diazepam;
(15) estazolam;
(16) ethinamate;
(17) ethylloflazepate;
(18) fludiazepam;
(19) flunitrazepam;
(20) flurazepam;
(21) halazepam;
(22) haloxazolam;
(23) ketazolam;
(24) loprazolam;
(25) lorazepam;
(26) lormetazepam;
(27) mebutamate;
(28) medazepam;
(29) methohexital;
(30) meprobamate;
(31) methylphenobarbital;
(32) nimetazepam;
(33) nitrozepam;
(34) nordiazepam;
(35) oxazepam;
(36) oxazolam;
(37) paraldehyde;
(38) petrichloral;
(39) phenobarbital;
(40) pinazepam;
(41) prazepam;
(42) temazepam;
(43) tetrazepam; and
(44) triazolam.
(c) Fenfluramine.- Substances listed in Schedule IV include:
(1) a material, compound, mixture, or preparation that contains fenfluramine; and
(2) if its existence is possible:
(i) a salt of fenfluramine;
(ii) an optical, position, or geometric isomer of fenfluramine; and
(iii) a salt of an isomer of fenfluramine.
(d) Stimulants.- Substances listed in Schedule IV include a material, compound, mixture, or preparation that contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:
(1) diethylpropion;
(2) pemoline, including organometallic complexes and their chelates; and
(3) phentermine.
(e) Exemptions.- By regulation, the Department may exempt from this section a compound, mixture, or preparation that contains a depressant substance listed in subsection (b) of this section if:
(1) the compound, mixture, or preparation contains an active medicinal ingredient that does not have a depressant effect on the central nervous system; and
(2) the admixtures are included in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances that have a depressant effect on the central nervous system.
(f) Required factors for adding substance.- The Department may not add a substance to Schedule IV under § 5-202 of this subtitle unless the Department finds that:
(1) the substance has a low potential for abuse relative to the substances listed in Schedule III;
(2) the substance has currently accepted medical use in treatment in the United States; and
(3) abuse of the substance may lead to limited physical dependence or psychological dependence relative to the substances in Schedule III.
[An. Code 1957, art. 27, § 279(d); 2002, ch. 26, § 2; 2003, ch. 21, § 1.]